| Nov 21 |
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
|
| Nov 18 |
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
|
| Nov 14 |
Intelligent gears up for FDA approval of fingerprint drug detection device
|
| Nov 13 |
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission
|
| Nov 10 |
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)
|
| Nov 7 |
Intelligent Bio Solutions GAAP EPS of -$0.70, revenue of $0.87M
|
| Nov 7 |
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights
|
| Nov 1 |
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
|
| Oct 31 |
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach
|
| Oct 29 |
Intelligent Bio Solutions sees Q1 revenue of $0.87M
|
